Perspective Therapeutics, Inc. Cash flow Statement
Figures in Million
Consolidated Cash Flow Results
Dec'24
Dec'23
Jun'22
Jun'21
Jun'20
Jun'19
No of Months
12
12
12
12
12
12
Profit Before Tax
-80.00
-40.00
-7.00
-3.00
-3.00
-5.00
Adjustment
0.00
0.00
0.00
0.00
0.00
0.00
Changes In working Capital
31.00
2.00
-1.00
0.00
0.00
0.00
Cash Flow after changes in Working Capital
0.00
0.00
0.00
0.00
0.00
0.00
Cash Flow from Operating Activities
-18.00
-36.00
-7.00
-2.00
-3.00
-5.00
Cash Flow from Investing Activities
-218.00
24.00
0.00
0.00
0.00
0.00
Cash Flow from Financing Activities
289.00
0.00
0.00
64.00
0.00
7.00
Net Cash Inflow / Outflow
52.00
-11.00
-7.00
61.00
-2.00
2.00
Opening Cash & Cash Equivalents
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent of Subsidiaries under liquidations
0.00
0.00
0.00
0.00
0.00
0.00
Translation adjustment on reserves / op cash balances foreign subsidiaries
0.00
0.00
0.00
0.00
0.00
0.00
Effect of Foreign Exchange Fluctuations
0.00
0.00
0.00
0.00
0.00
0.00
Closing Cash & Cash Equivalent
0.00
0.00
0.00
0.00
0.00
0.00
Figures in USD Million
Seasonal companies are compared with the same quarter last year
Seasonal companies are compared with the same quarter last year
Compare Cash Flow Results of Perspective Therapeutics, Inc.
Figures in Million
consolidated Cash Flow Results
Change(USD)
Change(%)
Profit Before Tax
-80.427
-16.328
-64.00
-392.57%
Adjustment
0
0
0.00
0.00%
Changes In working Capital
31.814
-0.839
31.00
3891.90%
Cash Flow after changes in Working Capital
0
0
0.00
0.00%
Cash Flow from Operating Activities
-18.294
-13.968
-5.00
-30.97%
Cash Flow from Investing Activities
-218.931
-0.084
-218.00
-260532.14%
Cash Flow from Financing Activities
289.385
16.121
273.00
1695.08%
Net Cash Inflow / Outflow
52.16
2.069
50.00
2421.02%
Opening Cash & Cash Equivalents
0
0
0.00
0.00%
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0
0
0.00
0.00%
Cash & Cash Equivalent of Subsidiaries under liquidations
0
0
0.00
0.00%
Translation adjustment on reserves / op cash balances foreign subsidiaries
0
0
0.00
0.00%
Effect of Foreign Exchange Fluctuations
0
0
0.00
0.00%
Closing Cash & Cash Equivalent
0
0
0.00
0.00%
Cash Flow - Snapshot (Consolidated) - Dec'24
YoY Growth in year ended Dec 2024 is 50.44% vs NA in Dec 2023
Dec'24
Dec'23
Change(%)
Cash Flow from Operating Activities
-18.29
-36.91
50.44%






